in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Recip Buys AstraZeneca Plant
6:21 AM MDT | August 7, 2007 | Chemical Week Editorial Staff
Recip Pharma (Haninge, Sweden), a contract manufacturer, says it has completed the acquisition of AstraZeneca’s sterile products manufacturing plant near Monts, France. Financial terms were not disclosed. Recip Pharma will operate the plant to manufacture and fill vials with a range of AstraZeneca’s anaesthetic products. The acquisition is Recip Pharma’s first outside of Sweden. AstraZeneca says it decided to sell the plant because of growing competition from generic anaesthetic manufacturers. All of AstraZeneca’s staff at the site has...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee